Camp4 Therapeutics (CAMP) Liabilities and Shareholders Equity (2023 - 2025)
Historic Liabilities and Shareholders Equity for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $86.4 million.
- Camp4 Therapeutics' Liabilities and Shareholders Equity rose 30439.52% to $86.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.8 million, marking a year-over-year increase of 26528.63%. This contributed to the annual value of $78.3 million for FY2024, which is 4251.63% up from last year.
- According to the latest figures from Q3 2025, Camp4 Therapeutics' Liabilities and Shareholders Equity is $86.4 million, which was up 30439.52% from $51.3 million recorded in Q2 2025.
- Camp4 Therapeutics' Liabilities and Shareholders Equity's 5-year high stood at $86.4 million during Q3 2025, with a 5-year trough of $21.4 million in Q3 2024.
- Over the past 3 years, Camp4 Therapeutics' median Liabilities and Shareholders Equity value was $58.9 million (recorded in 2023), while the average stood at $59.2 million.
- In the last 5 years, Camp4 Therapeutics' Liabilities and Shareholders Equity soared by 4251.63% in 2024 and then skyrocketed by 30439.52% in 2025.
- Camp4 Therapeutics' Liabilities and Shareholders Equity (Quarter) stood at $54.9 million in 2023, then skyrocketed by 42.52% to $78.3 million in 2024, then rose by 10.33% to $86.4 million in 2025.
- Its last three reported values are $86.4 million in Q3 2025, $51.3 million for Q2 2025, and $62.8 million during Q1 2025.